Analyst Opinions: Changes for Societe Generale, Sanofi, Renault...
This Friday, January 16, 2026, several brokers are adjusting their price targets on French and European stocks. The revisions particularly affect the banking, pharmaceutical, semiconductor, automotive, and real estate sectors.
SOCIETE GENERALE: Morgan Stanley initiates an overweight recommendation with a price target of €83. Goldman Sachs maintains its buy rating and raises its target from €72.75 to €73.25. Grupo Santander keeps its outperform recommendation and adjusts its target from €73.21 to €82.77.
SANOFI: Deutsche Bank maintains its buy rating and lowers its price target from €110 to €105.
ASM INTERNATIONAL: Morgan Stanley maintains its overweight recommendation and raises its target from €625 to €800.
STMICROELECTRONICS: TD Cowen maintains its hold rating and increases its price target from €21.50 to €27.50.
RENAULT: Citi maintains its buy recommendation and reduces its target from €42 to €38.
ORANGE: Deutsche Bank maintains its buy rating and raises its price target from €15.50 to €16.50.
OPMOBILITY: Deutsche Bank maintains its hold recommendation and increases its target from €12 to €14.
MEDINCELL: Oddo BHF maintains its outperform rating and raises its price target from €27 to €34.
ICADE: Oddo BHF maintains its underperform recommendation and lowers its target from €23 to €22.
GECINA: Oddo BHF maintains its outperform rating and reduces its price target from €108 to €98.
FONCIERE INEA: Oddo BHF downgrades its recommendation from outperform to hold with a price target of €37.
EXOSENS: Bernstein initiates an outperform recommendation with a price target of €61.
